Basics |
Company: |
Avanos Medical, Inc. |
IPO Date: |
October 20, 2014 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$799.19M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.52 | 1.59%
|
Avg Daily Range (30 D): |
$0.27 | 1.68%
|
Avg Daily Range (90 D): |
$0.26 | 1.41%
|
Institutional Daily Volume |
Avg Daily Volume: |
.25M |
Avg Daily Volume (30 D): |
.47M |
Avg Daily Volume (90 D): |
.28M |
Trade Size |
Avg Trade Size (Sh.): |
64 |
Avg Trade Size (Sh.) (30 D): |
69 |
Avg Trade Size (Sh.) (90 D): |
55 |
Institutional Trades |
Total Inst.Trades: |
2,462 |
Avg Inst. Trade: |
$1.58M |
Avg Inst. Trade (30 D): |
$1.48M |
Avg Inst. Trade (90 D): |
$1.23M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.57M |
Avg Closing Trade (30 D): |
$1.54M |
Avg Closing Trade (90 D): |
$1.2M |
Avg Closing Volume: |
50.03K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$.35
|
$.1
|
$.04
|
Diluted EPS
|
$.34
|
$.09
|
$.04
|
Revenue
|
$ 681.5M
|
$ 170.4M
|
$ 171.7M
|
Gross Profit
|
$ 378.3M
|
$ 92.9M
|
$ 95.6M
|
Net Income / Loss
|
$ 15.7M
|
$ 4.3M
|
$ 1.8M
|
Operating Income / Loss
|
$ 33.5M
|
$ 12M
|
$ 6.3M
|
Cost of Revenue
|
$ 303.2M
|
$ 77.5M
|
$ 76.1M
|
Net Cash Flow
|
$ -18.1M
|
$ -3.2M
|
$ 16.4M
|
PE Ratio
|
52.06
|
|
|
Splits |
May 15, 2006:
100:1
|
|